News

Anti-TNFs linked to lower heart attack risk in RA patients


 

AT RHEUMATOLOGY 2014

Dr. Low noted that the data on the use of steroids was quite crude and often the dose was not recorded, and even less information about NSAIDs was available. "This is something that we will have to work on, and it does remain to be a potential confounding factor in the analysis," she concluded.

The BSRBR is funded by a grant from the BSR, which receives funding from multiple drug companies. This income finances a separate contract between the BSR and the University of Manchester that provides and runs the BSRBR. Dr. Low had no personal conflicts of interest.

Pages

Recommended Reading

No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge Rheumatology
USPSTF: Insufficient evidence to judge vitamin supplements
MDedge Rheumatology
Obesity prevalence steady between 2003 and 2012
MDedge Rheumatology
TNF inhibitors reduce coronary artery disease risk in rheumatoid arthritis
MDedge Rheumatology
Colchicine may provide potent cardiac protection
MDedge Rheumatology
Apixaban approved for preventing DVT and pulmonary embolism after hip/knee surgery
MDedge Rheumatology
Ustekinumab again linked to cardiovascular events
MDedge Rheumatology
Men have more major complications after hip, knee replacement
MDedge Rheumatology
CDC: Policy changes could prevent 100,000 deaths a year
MDedge Rheumatology
OA-related walking disability on par with diabetes as CVD risk factor
MDedge Rheumatology